NewsCompany sought to block paper's publication
References (0)
Cited by (19)
Results registries for clinical trials - A milestone on the way to transparency in clinical research?
2010, Zeitschrift fur Evidenz, Fortbildung und Qualitat im GesundheitswesenAssociation of funding and findings of pharmaceutical research at a meeting of a medical professional society
2004, American Journal of MedicineCitation Excerpt :A second set of biases may result from the efforts of pharmaceutical companies to promote their products, which may be in conflict with the scientific impartiality among institutional decision-makers (3) and individual investigators (10). These efforts may include supporting biased study designs (e.g., those that include nonequivalent comparison interventions) (14,15), controlling access to and analysis of study data, and censoring or “spinning” the results (16–18). A third potential bias may stem from conflicts between investigators’ duty to conduct research objectively and their desire for professional recognition (e.g., by granting agencies and academic promotion committees) and financial reward.
Conflict of interest and the credibility of clinical medicine. A psychosomatic antidote
2002, International Congress SeriesPhysicians' interpretation of "class effects": A need for thoughtful re-evaluation
2002, Journal of the American College of CardiologyPitfalls and safeguards in industry-funded research
2020, Ochsner JournalComment les conflits d'intérêts peuvent influencer la recherche et l'expertise
2012, HERMES (France)
Copyright © 2000 Published by Elsevier Ltd. All rights reserved.